|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0007257,
umls-concept:C0010583,
umls-concept:C0015133,
umls-concept:C0030705,
umls-concept:C0194037,
umls-concept:C0332283,
umls-concept:C1512043,
umls-concept:C1514756,
umls-concept:C1518071,
umls-concept:C1522449
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1993-7-27
|
|
pubmed:abstractText |
To evaluate high-dose chemotherapy followed by autologous bone marrow transplantation (ABMT) in patients with lymphoid malignancy who had received prior radiation therapy.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1329-35
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8315430-Adolescent,
pubmed-meshheading:8315430-Adult,
pubmed-meshheading:8315430-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8315430-Bone Marrow Transplantation,
pubmed-meshheading:8315430-Carmustine,
pubmed-meshheading:8315430-Combined Modality Therapy,
pubmed-meshheading:8315430-Cyclophosphamide,
pubmed-meshheading:8315430-Etoposide,
pubmed-meshheading:8315430-Female,
pubmed-meshheading:8315430-Humans,
pubmed-meshheading:8315430-Lymphoma,
pubmed-meshheading:8315430-Male,
pubmed-meshheading:8315430-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:8315430-Transplantation, Autologous
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy.
|
|
pubmed:affiliation |
Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
